Clareon™ Aspheric Hydrophobic Acrylic IOL
- Risk class
- III
- Product type
- Invasive
- Brand name
- Clareon™
- Commercial name
- Intraocular lenses
- Sterilization method
- ETHYLENE OXIDE
- Analysis ID
- 38635efefb5905735d0b8a75a48b8885
- Registration date
- September 17, 2021
- Expiration date
- September 17, 2026
- Creation date
- September 17, 2021
- City
- CORK IRELAND
- Country
- IRELAND
- Address
- CORK BUSINESS & TECHNOLOGY PARK, MODEL FARM RD, CORK IRELAND
- Name
- ALCON LABORATORIES, INC.
- Country
- UNITED STATES
- Address
- AVENIDA AMAZONAS N37-29 AND NATIONAL UNION OF JOURNALISTS. EUROCENTER BUILDING. FLOOR 6
- Phone
- 23933020
THE CLAREON™ LIO IS DESIGNED TO BE IMPLANTED IN THE CAPSULAR SAC IN THE POSTERIOR CHAMBER OF THE EYE, REPLACING THE HUMAN LENS. THIS POSITION OF THE LENS ALLOWS THE LIO TO ACT AS A REFRACTIVE MEDIUM IN APHAKIA CORRECTION.
Access comprehensive regulatory information for Clareon™ Aspheric Hydrophobic Acrylic IOL in the Ecuador medical device market through Pure Global AI's free database. This III medical device is registered under ARCSA ID 38635efefb5905735d0b8a75a48b8885 and manufactured by ALCON LABORATORIES IRELAND LTD.. The device was registered on September 17, 2021.
This page provides complete registration details including product type (Invasive), manufacturer information, authorized representative details, and regulatory compliance data from the official Ecuador ARCSA medical device database. Pure Global AI offers free access to Ecuador's complete medical device registry.